Results 221 to 230 of about 606,957 (319)

Cellular Degeneration Associated with Characteristic Nuclear Fine Structural Changes in the Cells from two cases of Burkitt's Malignant Lymphoma Syndrome

, 1963
M. A. Epstein, Peter B. Herdson
openalex   +1 more source

Giant Follicular Lymphoma of the Spleen [PDF]

, 1964
Eliezer Robinson
openalex   +1 more source

Classification of Myelodysplastic, Myeloproliferative, and Myelodysplastic/Myeloproliferative Neoplasms: The Past, Present, and Future

American Journal of Hematology, EarlyView.
ABSTRACT With the recent publication of new classification systems of hematopoietic neoplasms, understanding how recognition of disease entities has occurred over time and the subsequent development of formal disease classifications is of importance. This review focuses on the early recognition of myeloid disorders, especially chronic myeloid disorders,
Daniel A. Arber, Attilio Orazi
wiley   +1 more source

Mapping the research landscape of PET/CT in lymphoma: insights from a bibliometric analysis. [PDF]

Front Oncol
Zhang D, Peng J, Zhu Y, Gong Q, Wang Q, Xiang C, Du H, Hu X.   +7 more
europepmc   +1 more source

Targeted Therapies in Myelofibrosis: Present Landscape, Ongoing Studies, and Future Perspectives

American Journal of Hematology, EarlyView.
ABSTRACT Myelofibrosis (MF) is a myeloproliferative neoplasm that is accompanied by driver JAK2, CALR, or MPL mutations in more than 90% of cases, leading to constitutive activation of the JAK–STAT pathway. MF is a multifaceted disease characterized by trilineage myeloid proliferation with prominent megakaryocyte atypia and bone marrow fibrosis, as ...
Giuseppe G. Loscocco, Paola Guglielmelli
wiley   +1 more source

Concurrent papillary thyroid carcinoma and incidental cervical lymph node indolent B cell non-Hodgkin lymphoma: clinicopathological features, outcomes, and potential relationships. [PDF]

World J Surg Oncol
Zhang Y, Song Y, Cheng R, Zhai Q.
europepmc   +1 more source

Abnormally high expression of CHI3L1 in peripheral blood mononuclear cells and serum and their potential diagnosis and prediction from lymphoma patients. [PDF]

Front Immunol
Wang C, Tang L, Luo H, Liang J, Huang Y, Guo K, Liu R, He Y, Gao Y, Lei M.   +9 more
europepmc   +1 more source

Inextricable association of connective tissue disease with B‑cell lymphoma (Review). [PDF]

Mol Clin Oncol
Ruan JS, Xu S, Shan NN.
europepmc   +1 more source

Elucidating the Molecular Landscape of Cystic Kidney Disease: Old Friends, New Friends and Some Surprises

American Journal of Medical Genetics Part A, EarlyView.
ABSTRACT Cystic kidney diseases (CyKD) are a diverse group of disorders affecting more than 1 in 1000 individuals. Over 120 genes are implicated, primarily encoding components of the primary cilium, transcription factors, and morphogens. Prognosis varies greatly by molecular diagnosis. Causal variants are not identified in 10%–60% of individuals due to
Deborah Watson, Frank Mentch, Jonathan Billings, Kayleigh Ostberg, Michael E. March, Jennifer M. Kalish, Dong Li, India Cannon, Lisa M. Guay‐Woodford, Erum Hartung, Alanna Strong   +10 more
wiley   +1 more source

NK/T-cell bone lymphoma-induced hemophagocytic lymphohistiocytosis: A clinical case report. [PDF]

Radiol Case Rep
Zhang Z, Chen F.
europepmc   +1 more source